C.I. Rojas

机构：Finis Terrae University

发表论文 17 篇 · 总被引 86 次 · h-index 3

代表论文

• Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial (2025 · Annals of Oncology · 被引 33)
• 65O CheckMate 73L: Phase III study comparing nivolumab (N) + concurrent chemoradiotherapy (CCRT) followed by N ± ipilimumab (I) v CCRT followed by durvalumab (D) for previously untreated, locally advanced stage (stg) III NSCLC (2024 · Immuno-Oncology Technology · 被引 22)
• 44O Updated results from a phase I study evaluating the KRAS G12C inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC (2024 · ESMO Open · 被引 13)
• 855P Safety and efficacy of vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo/pembro) in previously untreated advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II KEYVIBE-005 study (2024 · Annals of Oncology · 被引 3)
• 401P Vibostolimab coformulated with pembrolizumab (vibo/pembro) + chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study (2024 · Annals of Oncology · 被引 3)
• 21O Coformulated vibostolimab/pembrolizumab in advanced cervical cancer: KEYVIBE-005 (2024 · ESMO Open · 被引 3)